Lv110
40 积分 2025-03-14 加入
Preoperative tumour size assessment in patients with early-stage cervical cancer: Final results of the SENTIX study
26分钟前
求助中
Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial
1天前
已完结
Tumor “age” in early-onset colorectal cancer
1天前
已完结
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
1天前
已完结
Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study
1天前
已完结
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
2天前
已完结
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
2天前
已完结
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
2天前
已完结
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
2天前
求助中
Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trial
2天前
已完结
Th2 to Th1 Transition Is Required for Induction of Skin Lesions in an Inducible and Recurrent Murine Model of Cutaneous Lupus–Like Inflammation
26分钟前
待审核
In vivo macrophage engineering for renal cancer therapy
2小时前
待审核
骨质疏松症外伤后骨折的法医学鉴定
2小时前
已采纳
6岁以下儿童维生素A缺乏预防性补充的专家共识（2025）
1天前
待审核
经内镜胆道内支架放置术在老年急性梗阻性化脓性胆管炎中的应用价值
1天前
已采纳
Hypocrystalline ceramic aerogels for thermal insulation at extreme conditions
5天前
已驳回
白藜芦醇纳米乳的制备及其功能评价
5天前
已采纳
聚左旋乳酸和聚右旋乳酸可降解材料在医疗美容领域的应用现状
5天前
已采纳
皖公网安备34019202002308
